beijing jiashijia keji youxian gongsi – Trademark Portfolio
Entity Type: 99
beijing jiashijia keji youxian gongsi holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include VISIOYO. The owner is based in Beijing.
beijingshi chaoyangqu dongbaxiang,
dongxiaojing chanyeyuan,205hao Fquyiceng
Beijing 100018 , CN
Showing of trademarks Trademarks
Trademark Classifications
beijing jiashijia keji youxian gongsi's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does beijing jiashijia keji youxian gongsi have?
beijing jiashijia keji youxian gongsi has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending.
What trademark classes does beijing jiashijia keji youxian gongsi file in?
beijing jiashijia keji youxian gongsi files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 14 (Jewelry). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are beijing jiashijia keji youxian gongsi's most well-known trademarks?
beijing jiashijia keji youxian gongsi's registered trademark portfolio includes well-known marks such as VISIOYO. These are among 1 currently registered trademark in the portfolio.
What is beijing jiashijia keji youxian gongsi's trademark registration success rate?
beijing jiashijia keji youxian gongsi has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.